Hormone therapy: a revolution in understanding prostate cancer

被引:4
|
作者
Arya, Manit [1 ,2 ]
Shergill, Iqbal S.
Grange, Philippe [2 ]
Emberton, Mark
机构
[1] Univ Coll London Hosp, Dept Urol, Inst Urol, London WC1E 5DB, England
[2] Kings Coll Hosp London, London, England
来源
LANCET ONCOLOGY | 2008年 / 9卷 / 11期
关键词
D O I
10.1016/S1470-2045(08)70282-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1112 / 1112
页数:1
相关论文
共 50 条
  • [41] Morphologic effects of neoadjuvant hormone therapy on prostate cancer
    Têtu, B
    Van der Kwast, TH
    Fradet, Y
    Candas, B
    Gomez, JL
    Cusan, L
    Labrie, F
    MOLECULAR UROLOGY, 1998, 2 (03) : 103 - 107
  • [42] Medicare Reimbursement and Prescribing Hormone Therapy for Prostate Cancer
    Keating, Nancy L.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (24): : 1814 - 1815
  • [43] Fatigue in patients with prostate cancer receiving hormone therapy
    Stone, P
    Hardy, J
    Huddart, R
    A'Hern, R
    Richards, M
    EUROPEAN JOURNAL OF CANCER, 2000, 36 (09) : 1134 - 1141
  • [44] Intermittent hormone therapy with eligard in patients with prostate cancer
    Alekseev, B. Ya.
    Krasheninnikov, A. A.
    Nyushko, K. M.
    Kalpinsky, A. S.
    Kaprin, A. D.
    ONKOUROLOGIYA, 2014, 10 (01): : 69 - 75
  • [45] Management considerations for adjunct hormone therapy in prostate cancer
    Thompson, Claire
    Murray, Julia
    TRENDS IN UROLOGY & MENS HEALTH, 2023, 14 (06) : 17 - 22
  • [46] Advanced prostate cancer: Immediate or deferred hormone therapy?
    Newling, D
    EUROPEAN UROLOGY, 2001, 39 : 15 - 21
  • [47] What is new in hormone therapy for prostate cancer in 2007?
    Tombal, Bertrand
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (06) : 477 - 483
  • [48] Hormone Therapy for Prostate Cancer: Exploring Current Controversies
    Montorsi, Francesco
    Berges, Richard
    Irani, Jacques
    Schulman, Claude C.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (09) : 725 - 732
  • [49] Beyond Hormone Therapy for Prostate Cancer with PARP inhibitors
    de Bono, Johann Sebastian
    Sandhu, Shahneen
    Attard, Gerhardt
    CANCER CELL, 2011, 19 (05) : 573 - 574
  • [50] Combination therapy in hormone-refractory prostate cancer
    Daniel P. Petrylak
    Current Oncology Reports, 2001, 3 (5) : 453 - 453